BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35715440)

  • 21. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
    Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics of extrahepatic biliary neuroendocrine neoplasms in the gallbladder, extrahepatic biliary tract, and ampulla of Vater: A single-center cross-sectional study.
    Park YM; Seo HI; Noh BG; Kim S; Hong SB; Lee NK; Kim DU; Han SY
    Ann Hepatobiliary Pancreat Surg; 2023 Nov; 27(4):380-387. PubMed ID: 37840317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
    Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
    J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.
    Flemming JA; Zhang-Salomons J; Nanji S; Booth CM
    Cancer; 2016 Aug; 122(16):2534-43. PubMed ID: 27183133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descriptive epidemiology of biliary tract cancer incidence and geographic variation in Japan.
    Makiuchi T; Sobue T
    Eur J Cancer Prev; 2023 Jan; 32(1):2-9. PubMed ID: 35485392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sex in the outcomes of patients with biliary tract cancers remains unclear: A population-based study.
    Lemke M; DeWit Y; Nanji S; Booth CM; Flemming JA
    Am J Surg; 2018 Dec; 216(6):1118-1121. PubMed ID: 29934122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.
    Yoon JG; Kim MH; Jang M; Kim H; Hwang HK; Kang CM; Lee WJ; Kang B; Lee CK; Lee MG; Chung HC; Choi HJ; Park YN
    Hepatology; 2021 Oct; 74(4):1914-1931. PubMed ID: 33884649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
    J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
    Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carcinoma of the biliary tract].
    Miyazaki I; Konishi I; Nagakawa T
    Gan No Rinsho; 1986 Aug; 32(10):1365-8. PubMed ID: 3783969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal CTV selection according to primary tumour location and pT stage for biliary tract cancer.
    Socha J; Surdyka D; Kepka L
    J Med Imaging Radiat Oncol; 2019 Dec; 63(6):822-828. PubMed ID: 31402569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
    Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
    Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients.
    Juliusson G; Jonasson JG; Jonsdottir SB; Garcia HG; Olafsdottir E; Möller PH; Björnsson ES
    Scand J Gastroenterol; 2016 Dec; 51(12):1520-1525. PubMed ID: 27553174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.
    Yang JD; Kim B; Sanderson SO; Sauver JS; Yawn BP; Larson JJ; Therneau TM; Roberts LR; Gores GJ; Kim WR
    Am J Gastroenterol; 2012 Aug; 107(8):1256-62. PubMed ID: 22751468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic alterations in Japanese extrahepatic biliary tract cancer.
    Noguchi R; Yamaguchi K; Ikenoue T; Terakado Y; Ohta Y; Yamashita N; Kainuma O; Yokoi S; Maru Y; Nagase H; Furukawa Y
    Oncol Lett; 2017 Jul; 14(1):877-884. PubMed ID: 28693246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
    Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.